MBX Biosciences, Inc.
MBX
$10.79
$0.302.86%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 14.09% | -14.41% | -28.53% | -39.51% | 12.99% |
| Total Depreciation and Amortization | -22.67% | 19.05% | 31.25% | 17.07% | 2.50% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -81.33% | 25.15% | -55.90% | 123.63% | -15.37% |
| Change in Net Operating Assets | -122.63% | 37.25% | 365.21% | 115.20% | -259.38% |
| Cash from Operations | -9.36% | -10.50% | -23.90% | 3.91% | -44.27% |
| Capital Expenditure | -61.40% | 87.39% | -65.57% | -396.36% | -150.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 33.24% | -1,254.09% | -147.38% | 154.33% | -55.52% |
| Cash from Investing | 33.18% | -1,177.25% | -151.14% | 153.29% | -55.63% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.89% | 348,922.00% | -73.54% | 894.74% | 11.76% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -100.00% | -- | -- | -- | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 85.12% | -21.31% | -30,083.33% | -- | 100.00% |
| Cash from Financing | -100.06% | 13,490.91% | -1,062.30% | 863.16% | -99.97% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -169.39% | 625.09% | -567.61% | 112.23% | -195.06% |